Abstract
INTRODUCTION
Colorectal cancer is one of the three leading causes of cancer mortality worldwide. The progression of the cancer is due to an accumulation of genetic alteration in controlling growth and proliferation at numerous loci. As a model for both multistep and multipathway carcinogenesis, colorectal neoplastic progression provides paradigms of both oncogenes and tumor suppressor genes [1, 2] . The loss of heterozygosity (LOH) on tumor suppressor genes is believed as one of the key steps to carcinogenesis of colorectal cancer [3] . The loss of one allele at a specific locus is caused by a deletion mutation or loss of a chromosome from a chromosome pair [4] . When this occurs at a tumor suppressor gene with an abnormal allele, neoplastic transformation occurs. In colorectal cancers, frequent allelic loss has been identified in chromosome 5q (30%), 8p (40%), 17p (75-80%), 18q (80%), and 22q (20-30%) [5, 6] . Tumor suppressor genes APC, p53, and DCC were found to be located on chromosome 5q, 17p, and 18q, respectively. LOH analysis became an effective way to find informative loci candidate tumor suppressor genes afterwards [7, 8] . In this study we analyzed the LOH at 21 loci on chromosome 1 in sporadic colorectal cancers to identify additional loci involved in colorectal tumorigenesis.
MATERIALS AND METHODS

Materials
From 1998 to 1999, 83 consecutively collected tumors were treated surgically at Surgical Department of First People's Hospital in Shanghai Jiaotong University. There were 40 males and 43 females with a median age of 66 years (range 31-84). The diagnosis was verified pathologically. The number of Dukes stages A, B, C, D was 8, 21, 40 and 14, respectively. The number of proximal colon cancer, distal colon cancer, and rectal cancer was 33, 21 and 29, respectively. Well-differentiated adenocarcinomas, moderately differentiated adenocarcinomas and poorly differentiated adenocarcinomas were 23, 39 and 6, respectively, and mucinous adenocarcinomas were 15. HNPCC patients were ruled out by Amsterdam criteria [9, 10] . Informed consent to use surgical specimens in this study was obtained from patients.
Methods
DNA extraction
Thirty min after surgery, fresh cancerous and adjacent normal tissues were cut into approximately 2 mm 3 and immediately frozen in liquid nitrogen. DNA was extracted using standard method with proteinase K digestion and phenol/ chloroform purification. Microsatellite markers and PCR Twenty-one fluorescencelabeled primers for polymorphic microsatellite markers (Perkin-Elmer, USA), at a density of approximately one marker every 10 cm (Figure 1) [11] [12] [13] .
Figure 1
Twenty-one microsatellite markers on chromosome 1.
LOH analysis PCR product (0.5 µL) was mixed with 0.1 µL of Genescan 500 size standard (PE Applied Biosystems, USA) and 0.9 µL of formamide loading buffer. After denaturation at 96 for 5 min, products were eletrophoresed on 50 g/L polyacrylamide gels on an ABI 377 DNA sequencer (PE Applied Biosystems, USA) for 3 h. Genotype 2.1 software displayed individual gel lanes as electopherograms with a given size, height, and area for each detected fluorescent peak. Stringent criteria were used to score the samples. Alleles were defined as the two highest peaks within the expected size range. A ratio of T1:T2/N1:N2 less than 0.67 or greater than 1.50 was scored as a loss of heterozygosity ( Figure 2 ). Most amplifications of normal DNA producing two PCR products indicated preserve of heterozygosity. A single fragment amplified from normal DNA (homozygote) and fragments not clearly amplified from PCR reactions were scored as not informative. The LOH frequency of a locus was equal to the ratio of the number between allelic loss and informative cases. The average LOH frequency of chromosome 1 was the mean of the LOH frequency in all loci [14] [15] [16] [17] . Statistics χ 2 test was used to compare LOH with clinicopathological data. P<0.05 was considered statistically significant.
RESULTS
LOH of 21 microsatellite markers on chromosome 1
The average LOH frequency at chromosome 1, short arm and long arm was 19.83%, 18.00% and 21.66%, respectively. The two highest LOH loci with a frequency of 36.54% and 32.50% were identified on D1S468 (1p36.33-36.31) and D1S413 (1q31.3). Other loci also exhibited higher LOH frequencies, including D1S255 (1p34.1-32.3), D1S2868(1p22.1), D1S218 (1q24.1-24.3), D1S249 (1q32.2), D1S2800 (1q42.12-42.2) and D1S2836 (1q43-44) ( Table 1) .
Relationship of clinicopathological features and LOH on chromosome 1
On D1S2726 locus, LOH frequency of rectal cancer was 28.57% (6/21), which was higher than that of colon cancer (0%, 0/33) (P=0.002). No association between LOH of each marker on chromosome 1 and other clinicopathological data (patient sex, age, tumor size, growth pattern or Dukes stage) was observed. It indicated that LOH on chromosome 1 was a common phenomenon in all kinds of sporadic colorectal cancers (Tables 2A, 2B ). Table 2a Relationship between clinicopathological features and LOH of 11 loci on short arm of chromosome 1 
DISCUSSION
During tumorigenesis, loss of wild-type alleles (inherited from the non-mutation-carrying parents) is frequently observed. Loss of heterozygosity (LOH) on tumor suppressor genes played a key role in colorectal cancer transformation, and LOH analysis of sporadic colorectal cancers could help discover unknown tumor suppressor genes [7, 8] . In this study, LOH scanning was analyzed by Genotyper software in 83 sporadic colorectal cancer samples with 21 highly polymorphic markers, the ratio of the fluorescence intensity of alleles was studied to identify additional loci involved in colorectal tumorigenesis.
In this study, the average LOH frequency at chromosome 1 (19.83%), short arm (18.00%) and long arm (21.66%) was consistent with the previous study [5] . The two highest LOH loci with a frequency of 36.54% and 32.50% was identified on D1S468 (1p36.33-36.31) and D1S413 (1q31.3). There were few reports about the relationship between the long arm of chromosome 1 and colorectal cancer. But some previous studies showed that the 1q31-32 region frequently presented allelic loss in breast cancers and medulloblastomas. Pietsch et al. [18] found that 36% of medulloblastomas showed loss of heterozygosity (LOH) on chromosome 1q. The study of Benitez J showed more than 60% of breast tumors exhibited allelic loss in the 1q31-32 region [19] . These results suggested that putative tumor suppressor genes might locate on the 1q31-32 region. Our study also found that D1S413(1q31.3) exhibited a higher LOH frequency and that the LOH frequency of long arm of chromosome 1 was higher than that of short arm [5] . If D1S413 could be excluded, the LOH frequency of long arm was nearly equal to that of short arm. Thus, we hypothesized that the higher LOH frequency of D1S413 might be the reason why the LOH frequency of long arm of chromosome 1 was higher than that of short arm, suggesting the presence of a tumor suppressor gene in this region. This gene might be involved in the neoplastic process of colorectal cancer, breast cancer and medulloblastoma.
Previous studies showed that the 1p36 region frequently presented allelic loss in various cancers, such as colon cancer [20] , neuroblastoma [21] , hepatocellular carcinomas [22] , lung cancer [23] , and breast cancer [24] . But only NB gene was confirmed to be the tumor suppressor gene of neuroblastomas. In 1993, Tanaka et al. believed that a normal chromosome 1p36 might contain a tumor suppressor gene of colon carcinogenesis [25] . By database referring, we found TP73 gene (1p36) might be the known candidate tumor-suppressor genes related to colon cancer in this region. TP73, a novel family member of p53, was predicted to encode a protein with significant amino acid sequence similarity to p53 [29] . TP73 could inhibit cell growth in a p53-like manner by inducing apoptosis [27] . Kaghad et al. [26] regarded TP73 as a tumor suppressor gene. But Sunahara found that allelic loss of p73 occurred only in 17% of colorectal carcinomas, and suggested that p73 might not play a role as a tumor suppressor in colorectal carcinoma at least not in a classic Knudson manner [28] . In our study, the highest LOH frequency was exhibited in 1p36.33-36.31, and colorectal cancer related tumor suppressor gene (s) might locate in the region. TP73gene is a member of p53 family, its effect on colorectal carcinogenisis is not certain and requires further study. Due to many genes located in the region of 1p36.33-36.31, further LOH scanning with high-density microsatellite markers in the region is necessary in order to find new candidate genes.
No association between LOH markers on chromosome 1 and the clinicopathological data was found, indicating that LOH was a common phenomenon in all sporadic colorectal cancers. However, we found that on D1S2726 locus, LOH frequency of rectal cancer was high, no LOH was found in colon cancer. In 2001, Kapiteijn et al. [29] proposed that rectal cancer had more significant expression of p53 and more nuclear beta-catenin than colon cancer, and considered that the mechanism of carcinogenisis in distal colon was different from that in proximal colon. Our results could show that the mechanism of carcinogenisis in distal colon and rectum was not completely the same as in proximal colon.
Table 2b
Relationship between clinicopathological features and LOH of 10 loci on long arm of chromosome 1 Male  25  6  25  7  22  6  20  1  14  7  16  6  17  3  19  9  25  3  19  5   Female  23  5  30  3  20 10  18  2  13  6  20  4  24  5  26  3  23  7  17  7   Age (yr)  >60  37 10  43  6  30 14  28  3  18 10  28  7  33  6  33  10  39  10  26  9   60  11  1  12  4  12  2  10  0  9  3  8  3  8  2  12  2  9  0  10  3   Location  Proximal colon 14  6  20  4  16  5  15  1  10  6  17  3  15  2  15  6  18  6  16  5   Distal colon  14  3  14  4  14  4  10  1  7  3  4  2  12  3  14  1  14  2  6  5   Rectum  20  2  21  2  12  7  13  1  10  4  15  5  14  3  16  5  16  2 
